Clinical Factors Associated with COVID-19 Severity in Mexican Patients: Cross-Sectional Analysis from a Multicentric Hospital Study
Authors:
- Joel Monárrez-EspinoJMJoel Monárrez-Espino
- Carolina Ivette Zubía-NevárezCZCarolina Ivette Zubía-Nevárez
- Lorena Reyes-SilvaLRLorena Reyes-Silva
- Juan Pablo Castillo-PalenciaJCJuan Pablo Castillo-Palencia
- Julio Enrique Castañeda-DelgadoJCJulio Enrique Castañeda-Delgado
- Ana Sofía Herrera Van-OostdamAVAna Sofía Herrera Van-Oostdam
- Yamilé López-HernándezYLYamilé López-Hernández
Open Access
- 15 July 2021
- journal article
- research article
- Published by MDPI AG in Healthcare
- Vol. 9 (7) , 895
Abstract
(1) Background: Latin America has been harshly hit by SARS-CoV-2, but reporting from this region is still incomplete. This study aimed at identifying and comparing clinical characteristics of patients with COVID-19 at different stages of disease severity. (2) Methods: Cross-sectional multicentric study. Individuals with nasopharyngeal PCR were categorized into four groups: (1) negative, (2) positive, not hospitalized, (3) positive, hospitalized with/without supplementary oxygen, and (4) positive, intubated. Clinical and laboratory data were compared, using group 1 as the reference. Multivariate multinomial logistic regression was used to compare adjusted odds ratios. (3) Results: Nine variables remained in the model, explaining 76% of the variability. Men had increased odds, from 1.90 (95%CI 0.87–4.15) in the comparison of 2 vs. 1, to 3.66 (1.12–11.9) in 4 vs. 1. Diabetes and obesity were strong predictors. For diabetes, the odds for groups 2, 3, and 4 were 1.56 (0.29–8.16), 12.8 (2.50–65.8), and 16.1 (2.87–90.2); for obesity, these were 0.79 (0.31–2.05), 3.38 (1.04–10.9), and 4.10 (1.16–14.4), respectively. Fever, myalgia/arthralgia, cough, dyspnea, and neutrophilia were associated with the more severe COVID-19 group. Anosmia/dysgeusia were more likely to occur in group 2 (25.5; 2.51–259). (4) Conclusion: The results point to relevant differences in clinical and laboratory features of COVID-19 by level of severity that can be used in medical practice.Keywords
Funding Information
- Consejo Nacional de Innovación, Ciencia y Tecnología (311880)
This publication has 47 references indexed in Scilit:
- Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 CasesRadiology, 2020
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, ChinaJAMA Internal Medicine, 2020
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- COVID-19, ECMO, and lymphopenia: a word of cautionThe Lancet Respiratory Medicine, 2020
- Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19Journal of Medical Virology, 2020
- COVID-19: consider cytokine storm syndromes and immunosuppressionThe Lancet, 2020
- Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19)Journal of General Internal Medicine, 2020
- Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, ChinaIntensive Care Medicine, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Drug-resistant enteric fever worldwide, 1990 to 2018: a systematic review and meta-analysisBMC Medicine, 2020